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Abstract
This article highlights the expanding
burden of osteoporosis in West Virginia.
WV ranks second nationally in the
percentage of its population that is ≥ 65
years of age.1,2 Our older population
increases the risk of osteoporosis and
fracture; the most recent data indicates
that 77% of our women age 50 and older
have osteoporosis or low bone mass.3
The lifetime risk of osteoporotic related
fracture is alarming and occurs in 50% of
females and 25% of males age 50 and
older.3,4 The risk of osteoporosis related
hip fracture in women is equal to the
combined risk of breast, uterine or ovarian
cancer with the annual risk of osteoporotic
fracture greater than the combined risk of
breast cancer, stroke and heart attack.3,5,6
Detecting individuals at risk for fracture
has been aided by an internationally
validated fracture prediction tool from the
World Health Organization -- FRAX®. The
FRAX® tool can be incorporated into
protocols to help minimize barriers to
effective osteoporosis screening and
treatment in WV.

Introduction
Health promotion and disease
prevention for the expanding elderly
population is a major challenge
facing our state and the nation.1,2,7
In 2004, the United States Surgeon
General published Bone Health and
Osteoporosis: A Report of the Surgeon
General and the WV Department
of Health and Human Resources
published The Burden of Osteoporosis
in West Virginia.3,8 Both reports
highlight the burden of bone
disease as a major public health
and economic problem with total
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national costs estimated to be $140
billion by 2040.3,9,10 The estimated
economic toll of osteoporosis related
fragility fractures in West Virginia
was reported in this Journal with
current screening and treatment
protocols providing minimal cost
savings for our state.11 However,
improved screening and treatment
protocols aimed at identifying
individuals at greatest risk of fracture
have been developed and validated
thereby reducing the fracture
incidence and the fiscal burden
associated with fracture care.12-19
These bone health assessment tools
can be easily incorporated into
existing practices and will help
minimize the significant barriers to
evidence-based health promotion
programs and health care services
in WV.20,21 Before discussing the use
of fracture prediction algorithms,
an understanding of the evolving
definition of osteoporosis is needed.
Osteoporosis is a skeletal disorder
characterized by low bone strength
and increased risk of fracture.22 This
definition has evolved from the
1994 World Health Organization
(WHO) definition of osteoporosis
which was based solely on bone
mineral density (BMD) testing and
T-score generation.13 A T-score is
the number of standard deviations
a patient’s bone density varies from
a healthy, thirty-year-old reference
value. Osteopenia is defined as a
T-score that is between 1 and 2.5
standard deviations below this
reference value (T-score -1.0 to -2.5
= osteopenia) while osteoporosis is
a T-score at or below -2.5 (Figure 1).
The critical problem with the
original WHO definition is that

the majority of fragility fractures
occur in the osteopenic range and
not in the -2.5 T-score cut off value
for osteoporosis.17,23,24 Therefore,
generation of a T-score following
BMD testing will not allow one to
effectively predict fracture risk. For
example, identical T-scores of -2.5
in two women (a 50-year-old and
80-year-old), would not produce the
same fracture risk. The 80-year-old
has a fivefold higher probability of
hip fracture with age being a major
independent determinant of fracture
risk (Figure 2).25,26 The improved
screening tools used to predict an
individual’s absolute risk of fracture
take into account both modifiable
and non-modifiable variables.
Based solely on the non-modifiable
risk factors of age, race and gender,
the state of West Virginia is at
high risk for low bone mass and
osteoporosis. Older, Caucasian
women are at the highest risk of
developing osteoporosis and fracture;
West Virginia is predominantly
Caucasian (94.4%) and female
(51.1%).1-3 WV is second nationally
in the percent of population ≥ 65
years of age (15.7%) with 77% of
our women age 50 and older having
osteoporosis or low bone mass.2,3
Modifiable risk factors like smoking,
physical activity and alcohol
consumption also contribute to
our state’s prevalence of low bone
mass and osteoporosis. The state’s
smoking prevalence (28.2%) and
level of physical inactivity (31.7%)
are both higher than the national
averages of 19.7% and 24.0%,
respectively.21 Heavy alcohol use,
defined as at least five alcoholic
drinks for men or at least four drinks
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for women on a single occasion in
the past month, occurs in 11.1%
of West Virginia residents.21 At
present, the National Osteoporosis
Foundation estimates that there are
369,900 women and men in West
Virginia with either osteoporosis
or low bone mass. This number is
predicted to climb to nearly 466,300
by 2020.3,4 Increased prevalence of
low bone mass and osteoporosis
make fracture more likely.
Estimates of the number of
osteoporotic fractures in West
Virginia, including the associated
morbidity and mortality, are
disturbing. Over 179,000 osteoporotic
related fractures are predicted in WV
women during the 20 year period
from 1995-2015.3 These estimates
include 100,000 vertebral fractures,
41,000 hip fractures and 38,500
wrist fractures. Twenty-four percent
of women aged 50 and above die
within one year of a hip fracture.3,6

Twenty percent of previously
ambulatory persons will require
permanent long-term care after a
hip fracture.6 It is important to note
that a woman’s combined risk of
breast, uterine and ovarian cancer is
equal to her risk of sustaining a hip
fracture; the combined incidence of
breast cancer, stroke and heart attack
are not equal to the annual risk of
osteoporotic fracture (Table 1).3,6,27
Healthcare costs associated with
fragility fractures also surpass
the costs of treating breast cancer,
stroke and heart disease.10,27

Barriers to Improved Bone
Health in West Virginia
Early recognition of osteoporosis
can be difficult as bone loss is
considered a “silent disease,” often
asymptomatic until structural
failure and fracture occur. In
patients without fracture, central
dual-energy X-ray absorptiometry

Table 1: Osteoporotic Fractures
Compared to Other Diseases.

Osteoporotic Fractures

Annual
Incidence
2,000,000

Heart Attack

513,000

Stroke

228,000

Breast Cancer

184,300

(DXA) is the preferred modality for
the measurement of bone mineral
density.28 Access to existing bone
health management resources is
critically linked to the success of any
treatment program.29 However, DXA
is not available in all 55 counties in
WV. In 2004, according to the West
Virginia Osteoporosis Prevention
Program, only 24 counties had
access to DXA scans.3 Persons who
must travel between 10 and 24 miles
are 20% less likely to receive DXA
screening than those who travel less

Beckley ARH
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have serious issues.
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Figure 1. Most Fractures Do Not Occur in Patients with Osteoporosis.

Fracture rate (y-axis; wider bars) increases as the T-score moves further below the young
adult mean (x-axis). However, an increased number of fractures (z-axis; narrow bars)
occur in patients with osteopenia (the T-score range of 1 to 2.5 standard deviations
below the mean; rectangle area). Source: International Osteoporosis Foundation FRAX®
teaching slide kit at www.iofbonehealth.org/health-professionals/educational-tools-andslide-kits.html

than five miles.30 The rural nature
of our state adds to the difficulty of
managing the osteoporosis epidemic.
West Virginia is the second most
rural state in the country with 64% of
the population living in communities
of less than 2,500 people.31 Rural
residents rely more on the availability
of DXA from free-standing, nonfacility providers.30 Legislative and
regulatory changes have affected
the level of reimbursement for
DXA scanning with significant
reductions in the RVUs assigned to
central DXA (CPT 77080). In 2006,
Medicare DXA reimbursement was
approximately $139. In 2007, DXA
payment in free-standing facilities
was cut by about 40%. Additional
cuts in 2010 have decreased
reimbursement to $56. This legislative
response to a critical component for
effective osteoporosis evaluation
and management is disconcerting.
Current health care reform addresses
14   West Virginia Medical Journal

DXA reimbursement in the Senate
bill but not in House legislation. The
ultimate effect is pending with the
anticipated closing of free-standing
DXA facilities, comprising two-thirds
of all facilities in the state. If access
to the preferred testing modality
is limited, is there still a way to
predict fracture risk in patients?

Fracture Risk Assessment
The evolving definition of
osteoporosis has expanded to include
fracture risk instead of just BMD.
Risk assessment and intervention
protocols only offering treatment
to people with T-scores in the
osteoporosis range will not address
the majority of fractures which
occur in patients with osteopenia
(T-score -1 to -2.5) (Figure 1). One
of the most recent advances in
identifying individuals at risk of
sustaining fragility fracture is the
internationally validated WHO

fracture risk algorithm (FRAX® tool,
available online at www.shef.ac.uk/
FRAX).27 FRAX® provides a tool to
predict the 10-year absolute risk,
rather than relative risk, of sustaining
a future hip or major osteoporotic
fracture (wrist, proximal humerus,
hip or clinical vertebral fracture).
The FRAX® tool determines the
absolute risk through the integration
of independent risk factors present in
the patient. Risk factors incorporated
into the FRAX® algorithm consist of
country of origin, age, gender, BMI,
previous fracture, parental history
of hip fracture, current smoking,
use of glucocorticoids, rheumatoid
arthritis, secondary osteoporosis,
alcohol consumption and, when
available, BMD at the femoral neck
(g/cm2) obtained by DXA (Figure 3).
The algorithm corrects for the
different contributions of each
independent risk factor to yield the
ten year probability of sustaining
either a hip fracture or other major
osteoporotic fracture.27 When the
absolute risk of sustaining a hip
fracture within the next ten years
is 3% or above, or the risk of major
orthopaedic fracture is 20% or above,
treatment is considered cost effective
and has been shown to decrease
the rate of subsequent fractures.1219
Current National Osteoporosis
Foundation recommendations for
treatment include incorporation
of FRAX® for T-scores between
-1 and -2.5 in addition to
treatment recommendations
for (1) patients with a history of
hip or vertebral fracture and (2)
patients with a femoral neck or
spine T-score -2.5 or lower.
One of the major benefits of FRAX®
is that BMD measurement by DXA
scan is not required to calculate
fracture risk. This functionality
provides a significant advantage
to the 31 counties in West Virginia
that do not have access to DXA.
When the tool is used without BMD
testing data, the algorithm will take
into account secondary osteoporosis
risk factors (Table 2). Of note, the
predictive value of FRAX® without
BMD data is greater than or equal to
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Figure 2. Age and Bone Mineral Density are Major Independent Determinants

of Fracture Risk. At the same BMD (T-score -2.5), an 80-year-old female has over a
fivefold greater risk of fracture than a 50-year-old. Source: International Osteoporosis
Foundation FRAX® teaching slide kit at www.iofbonehealth.org/health-professionals/
educational-tools-and-slide-kits.html

Table 2: Secondary Osteoporosis and FRAX®.
Secondary Osteoporosis Variables Used in FRAX®
Diseases

Conditions

Drugs

Hypogonadism (premature)

Anorexia

Glucocorticoids

Diabetes

Alcoholism

Excess thyroxine

Depression

Hypercalciuria

Antiepileptics

COPD

Vitamin D Deficiency

Depo-provera

GI diseases (malabsorption)

GnRH agonists

Rheumatoid arthritis

Aromatase inhibitors

Cholestatic liver disease

SSRIs

Hyperthyroidism

Proton pump
inhibitors

Hyperparathyroidism

TZDs

the predictive value of BMD alone
when predicting the ten year hip
fracture risk.32 FRAX® assumes that
most diseases and medications (other

than rheumatoid arthritis) increase
fracture risk by causing bone loss.
When FRAX® is calculated without
BMD, a “yes” answer to question #10

(secondary osteoporosis) increases
the fracture risk (Figure 3). If BMD
is included, FRAX® ignores the “yes”
answer to secondary osteoporosis
and uses the actual BMD instead.
FRAX® does have some limitations:
(1) the model is relevant only for
untreated patients and should not be
used to follow treatment protocols.
(2) The model only accepts ages
between 40 and 90 years. If a patient
is younger or older, the program
will compute probabilities at 40
and 90 years, respectively. (3) The
model does not take into account
the number of prior fractures. Prior
fracture is defined as a previous
fragility fracture after 40 years of
age excluding fractures of the face,
fingers and toes. (4) The model does
not account for dose response effects
of smoking or glucocorticoid use.
Smoking applies to current use only
and glucocorticoid use with oral
steroids of ≥ 5mg/day prednisone
equivalent or ≥ 3 months. (5) The
model uses femoral neck BMD only
in g/cm2 and not BMD of the spine.
(6) The model generates a T-score
based on NHANES III young white
female normative database from
1998. The FRAX® generated T-score
can vary from the result produced
following DXA due to use of different
normative databases. (7) The model
does not account for the effect of
vitamin D deficiency (low serum
levels of 25-hydroxyvitamin D)
unless calculations occur without
BMD testing where secondary
osteoporosis can be marked as “yes”
(Table 2). (8) The model does not
account for patient factors that can
increase fracture risk including
visual acuity, fall risk or level of
physical activity. (9) The model
originally overestimated fracture risk.
Readjustments of the hip and major
fracture rates were completed in July
2009 based on new epidemiologic
data on fractures and mortality
rates in the USA (version 3).
If one is concerned by these
limitations, there are alternative
methods of fracture risk
determination.33 However, FRAX®
September/October 2011 | Vol. 107   15
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Figure 3. FRAX® WHO Fracture Risk Assessment Tool: www.shef.ac.uk/

FRAX. The US Caucasian calculation tool is shown. In this example a 5’6”, 124 lb 65year-old patient has current alcohol and smoking use and had a mother with a history of
fractured hip as well. The height and weight is entered and the FRAX® tool converts the
measurements to kg and cm and automatically populates questions #3 and #4 as well as
calculates the BMI of 20.0. Questions are answered following patient history with the
BMD measurement entered for #12 which has a drop down menu to select the scanner
used for testing (note: determination can be completed without BMD measurements). In
this patient, a Hologic scanner was used with femoral neck BMD 0.59 g/cm2. FRAX®
generates the T-score based on its normative data set (T-score -2.2, which would frequently
not generate pharmacologic management). For this example patient, the ten year absolute
risk of hip fracture is 5.1% and major osteoporotic fracture is 23%. The fracture risk
determination would support the decision for pharmacological management in this
patient which would not have been supported using BMD and T-score alone.

major osteoporotic fracture. When
the absolute risk of sustaining a hip
fracture within the next ten years
is 3% or above, or the risk of major
orthopaedic fracture is 20% or above,
treatment is considered cost effective
and has been shown to decrease
the rate of subsequent fractures.
Incorporation of this internationally
validated screening tool into clinical
practice would be expected to help
minimize the expanding burden
of osteoporosis in West Virginia.

Available Visual References
Osteoporotic Fracture Probability
is Country Specific. (Available for
viewing at www.iofbonehealth.org/
health-professionals/educationaltools-and-slide-kits.html.) There is
over a tenfold variation of osteoporotic
fracture probability depending on
country of origin with US Caucasians
having the greatest fracture risk.
Within the US, Caucasians have the
greatest risk of fracture followed by US
Hispanics, US Asians and US African
Americans. Females have a greater risk
of osteoporotic fracture in all countries.

is internationally validated and can
serve to enhance clinical judgment
of the physician, especially when
access to appropriate bone health
resources is limited. FRAX® provides
a clear-cut identification of patients
at risk for fracture, facilitating
discussion and treatment decisions
including medication avoidance in
patients with low risk for fracture.

Conclusions
Osteoporosis is a major public
health concern in West Virginia.
Our state has taken an active role in
the management of this epidemic
by establishing the Osteoporosis
16   West Virginia Medical Journal

and Arthritis Plan with priorities
established by the passage of House
Bill 4198 (Osteoporosis) and House
Bill 4685 (Arthritis) in 1996. Part of
the goal of this paper is to present
evidence-based tools not included in
the programs promoted by this Plan.
Our state’s residents are
particularly susceptible to low
bone mass and osteoporosis due
to demographics, poor bone health
indicators and access barriers to
evidence-based health promotion
and care services. The new FRAX®
tool is available for free online at
http://www.shef.ac.uk/FRAX/
and is used to generate the patient’s
ten year absolute risk of hip and

Accumulation of Risk Factors
Increases the Fracture Probability.
(Available for viewing at www.
iofbonehealth.org/healthprofessionals/educational-toolsand-slide-kits.html.) For the same
BMD, BMI and age, fracture probability
varies depending on the accumulation
of clinical independent risk factors for
fracture. This increase in fracture risk is
greater than predicted from BMD alone.
FRAX® takes into account the complex
relationships among risk factors to
provide a ten year absolute fracture risk.
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